LOGIN
AAOS: Quantitative ultrasound can detect the effects of risendronate on bone strength
March 2014
AAOS: Quantitative ultrasound can detect the effects of risendronate on bone strength
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Effects of Risendronate Assessed by Bone QUS: A Randomized Trial in 100 Women After Hip Fracture
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
138 women (100 at final follow-up) who underwent short proximal femoral nailing for a low-energy intertrochanteric fracture were randomized to receive either risendronate (75 mg twice monthly) or a placebo equivalent. The purpose of this study was to examine whether quantitative ultrasound was able to detect the effects of risendronate on bone strength, as confirmed by the incidence of re-fracture...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.